Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

PHP urges Assura shareholders to take no action on KKR offer

(Sharecast News) - The battle to take over Assura looks far from over after Primary Health Properties said it was considering its options as its bid for the medical property owner was trumped by private equity giant KKR on Wednesday. KKR and bid partner Stonepeak upped their offer for the National Health Service landlord on Wednesday to £1.7bn and garnered the support of Assura's board in the process.

PHP said its board "strongly disagrees with the Assura board's assessment" and would set out its detailed views in due course, adding that a government spending revue announcement - also published after the KKR deal became public -was "positive for both the PHP and Assura businesses".

The government set out plans to lift health day-to-day spending by 3% a year, in real terms, equivalent to approximately £29bn a year of extra cash, PHP said.

"Furthermore, the board of PHP expects the upcoming 10-year plan on healthcare to be equally positive and to provide a boost to primary care as the government shifts toward community, primary and preventive care in the future."

"PHP is considering its options and a further announcement will be made when appropriate. Assura shareholders are strongly advised to take no action in response to the announcement by Bidco (KKR) in the meantime."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.